Logotype for Blu Label Unlimited Group Limited

Blu Label Unlimited Group (BLU) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Blu Label Unlimited Group Limited

H1 2025 earnings summary

27 Aug, 2026

Executive summary

  • Strategy is built on eight pillars: technology, product, distribution, energy, treasury/procurement, special projects, postpaid, and Cell C, with a CAPEX-light model and focus on proprietary platforms and data analytics for innovation.

  • Product innovation includes Blu Voucher, Ringas, UniPIN, Blu Advance, and Ticketpro, with strong Blu Voucher sales and new emergency electricity top-up products.

  • Distribution spans formal, informal, banking, and petroleum sectors, with the Blue Train Group initiative for employment and training.

  • Energy segment (Cigicell/BluEnergy) expands from token vending to revenue assurance and green energy production for municipalities.

  • Brand and MVNO business showed notable momentum, with recognition for best video experience in South Africa.

Financial highlights

  • Effective revenue for the half year rose 8% year-over-year to R47.4 billion (reported revenue R7.2 billion due to PINless accounting).

  • Gross profit increased 2% to R1.63 billion, with gross margin up to 22.44%.

  • Core headline earnings per share up 0.4% to 47.20 cents.

  • EBITDA decreased 6% to R653 million, mainly due to lower CEC subscriber base and higher finance costs.

  • Net profit after tax was R395 million; capital and reserves at R5.5 billion.

Outlook and guidance

  • Management expects continued growth in gross revenue from universal vouchers and prepaid electricity, supported by NERSA-approved tariff adjustments and increased consumption.

  • Focus on executing strategic priorities, integrating postpaid business, investing in digital platforms, and accelerating MVNO and B2B growth.

  • No further Blu Label cash injections into Cell C anticipated; Cell C is self-sustaining.

  • Dividend payments may resume in 2024, pending board approval.

  • Consolidation of Cell C into Blu Label group delayed until after May 2025, pending regulatory approval.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more